SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pernix Therapeutics Holdings, Inc. – ‘S-3/A’ on 1/30/15 – EX-23.1

On:  Friday, 1/30/15, at 4:36pm ET   ·   Accession #:  1354488-15-393   ·   File #:  333-200011

Previous ‘S-3’:  ‘S-3’ on 11/7/14   ·   Next:  ‘S-3/A’ on 7/29/15   ·   Latest:  ‘S-3’ on 11/22/17

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/30/15  Pernix Therapeutics Holdings, Inc S-3/A                  5:441K                                   Issuer Direct/FA

Pre-Effective Amendment to Registration Statement for Securities Offered Pursuant to a Transaction   —   Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3/A       Form S-3/A Registration Statement                   HTML    194K 
 2: EX-4.6      Form of Warrant to Purchase Common Stock            HTML     67K 
 3: EX-5.1      Opinion of Goodwin Procter LLP                      HTML     10K 
 4: EX-23.1     Consent of Cherry Bekaert LLP                       HTML      6K 
 5: EX-23.2     Consent of Pricewaterhousecoopers LLP               HTML      6K 


EX-23.1   —   Consent of Cherry Bekaert LLP


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-3 /A ) and related Prospectus of Pernix Therapeutics Holdings, Inc., and to the incorporation by reference therein of (i) our report dated March 17, 2014, with respect to the consolidated financial statements and the effectiveness of internal controls over financial reporting of Pernix Therapeutics Holdings, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2013, and (ii) our report dated October 8, 2014 with respect to the Statement of Assets Acquired (audited) of the Treximet® product line as of August 20, 2014, included in its Current Report on Form 8-K/A dated August 19, 2014, each filed with the Securities and Exchange Commission. 
 
/s/ Cherry Bekaert LLP
 
Atlanta, Georgia
 
January 30, 2015
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-3/A’ Filing    Date    Other Filings
Filed on:1/30/158-K
10/8/14
8/20/14
8/19/148-K,  8-K/A
3/17/1410-K,  3,  4,  8-K
12/31/1310-K
 List all Filings 
Top
Filing Submission 0001354488-15-000393   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 5:43:19.1pm ET